Authors: Zujajah Gull, Zahra Anwar, Bushra Ali Sherazi
Abstract
Hypertension is common in patients of end stage renal disease treated with hemodialysis. Objective: To observe management of hypertension and antihypertensive drug profile in end stage renal disease (ESRD) patients undergoing hemodialysis. Methods: An observational study was conducted for 2 months (August 2015) - September 2015) in different hospitals of Lahore. Population of 50 dialysis ward patients was randomly selected during this period and study was performed by filling data collection forms from patients. Collected data was analyzed and results were presented in the form of graphs and tables. Results: Of the total patients, 56% were male and 44% were female. Hypertension (62%) and diabetes (20%) are leading cause of CKD. 76% patients were on low sodium diet and only 40% do exercise to control their blood pressure. 78% patients use calcium channel blockers alone or in combination with alpha or beta blockers as antihypertensive agents. Conclusion: Treatment with agents that lower blood pressure should routinely be considered for individuals undergoing dialysis to reduce the very high cardiovascular morbidity and mortality rate in this population. At the same time educating the patients regarding restricting the dietary salt or fluid intake will enable them to control their blood pressure and improve their quality of life.
Keywords: hypertension, ESRD, CKD, antihypertensive drug profile.
